Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

FONDAPARINUX vs FOSAPREPITANT: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

FONDAPARINUX vs FOSAPREPITANT: Safety Overview

Metric FONDAPARINUX FOSAPREPITANT
Total FAERS Reports 2,230 487
Deaths Reported 308 154
Death Rate 13.8% 31.6%
Hospitalizations 1,141 264
Average Patient Age 63.2 yrs 49.6 yrs
% Female Patients 56.5% 83.0%
FDA Approval Date Aug 19, 2024 N/A
Manufacturer Dr. Reddy's Laboratories Limited N/A
Route SUBCUTANEOUS N/A
Marketing Status Prescription N/A